Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-032426
Filing Date
2014-05-08
Accepted
2014-05-08 21:25:45
Documents
1
Period of Report
2014-05-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 30013
  Complete submission text file 0001209191-14-032426.txt   31468
Mailing Address 3501-C TRICENTER BLVD DURHAM NC 27713
Business Address 3501-C TRICENTER BLVD DURHAM NC 27713 919-544-8600
SCYNEXIS INC (Issuer) CIK: 0001178253 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations

Mailing Address 47 AVENUE DE L?OPERA PARIS I0 75002
Business Address 47 AVENUE DE L?OPERA PARIS I0 75002 01-83-79-81-91
Ventech Capital II (Reporting) CIK: 0001604072 (see all company filings)

State of Incorp.: I0 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36365 | Film No.: 14826773